Tirzepatide

Tirzepatide is a novel dual-agonist peptide designed to target GLP-1 and GIP receptors involved in metabolic regulation. Research has shown that Tirzepatide may support significant improvements in glucose control, promote substantial weight loss, and enhance insulin sensitivity. It acts by mimicking and activating these gut hormones to regulate appetite, energy expenditure, and metabolic function. This peptide is being explored for its potential in treating metabolic disorders such as type 2 diabetes and obesity. Its dual-target mechanism offers a promising approach to comprehensive metabolic health management.

STRICTLY FOR LABORATORY RESEARCH USE ONLY.

Purity >99%

Peptides will arrive in a lyophilized (powder) form for maximum stability